Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy - Test2 - elhamkhani - TriplyDB

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy

http://www.wikidata.org/entity/Q26801593

about

Drugging the Cancers Addicted to DNA Repair.The FANCD2-FANCI complex is recruited to DNA interstrand crosslinks before monoubiquitination of FANCD2.Strategic role of the ubiquitin-dependent segregase p97 (VCP or Cdc48) in DNA replication.The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways.Involvement of FANCD2 in Energy Metabolism via ATP5α.FBW7 regulates DNA interstrand cross-link repair by modulating FAAP20 degradation.BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy.

P2860

Q33702497-F7906C8C-42AA-448E-A5ED-F0BE6D655994 Q37099432-AF71799F-DC61-44A9-AAE1-9647D817ACAD Q38810286-D513872F-A179-401D-8FA5-4B6C9288BC68 Q39116600-041E840B-ED25-4A88-BB6F-810F58728FB7 Q40961568-E0D6DBBF-A430-4099-87FE-42877E89B036 Q41667106-C7E9B7BA-ED85-45C0-BD33-0EB5559F81A6 Q48309954-E1A3AF0F-E951-445A-A882-C4E4DC7B3BC0

P2860

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy

http://www.wikidata.org/entity/Q26801593

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy

@ast

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy

@en

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy

@nl

type

label

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy

@ast

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy

@en

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy

@nl

prefLabel

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy

@ast

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy

@en

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy

@nl

P1433

Q26801593-DE8361DD-B649-4272-8209-1694FC448255

P1476

Q26801593-2291634F-A251-4436-A308-6D5039A518A2

P2093

Q26801593-9EDD6F82-D4DD-4BE7-915D-C9C82B170CA1

Q26801593-FDEE6637-25CC-4A96-9839-7987828A1029

P2860

Q26801593-047B25CB-81C0-4AF9-A0BB-99D7AA6AF6CF

Q26801593-07AF33CE-2BD4-4C24-8E93-10FA72CDCDD3

Q26801593-0891372D-8D83-4B8F-922A-1F7CC49B8F38

Q26801593-08B8019C-38F0-4BAA-A098-C62E482F0FBF

Q26801593-08EB4C40-3B76-4FAC-B46C-6079B15F7CA1

Q26801593-0B8C9EC9-DE7E-462D-AF90-96A102B1EC57

Q26801593-0BD04ADD-DEE3-4F65-B3CF-70931908B49E

Q26801593-0DF9663C-F754-464C-BFB8-71B5BDDD2522

Q26801593-0E1B47BC-27B7-4C4B-8A2C-235A846F73D2

Q26801593-13424934-B20A-44A9-8586-2A237499522C

P304

Q26801593-7D1D28C0-A256-4615-8B90-F44F69ADB842

P31

Q26801593-042203C3-C733-4BB3-B88F-698DC0C1D569

Q26801593-D9B634E5-F21E-42DC-9E40-EF73D1AA32FE

P3181

Q26801593-69BE7B9F-4FBA-4518-BFDB-9841D749D26B

P356

Q26801593-85CCD0FA-D22C-460A-B6EC-26B3F71C3060

P407

Q26801593-A5A43F2E-1318-431E-905D-41EB170E01DD

P433

Q26801593-99F4B092-E3A0-4815-A99B-7D1FAFCB136E

P478

Q26801593-E6B32783-628D-4CBC-9FFE-43742C461AED

P577

Q26801593-4F820C58-500B-4CC9-8E0A-C0F229967405

Q26801593-FAF3EF4E-5182-411A-87BD-B4F696AD7BF7

P5875

Q26801593-94CCFCAD-6894-4CEF-8845-947F2E2DF064

P698

Q26801593-B4F37419-B895-427B-A2DD-A61ABE8FB362

P921

Q26801593-2FD64B47-CE2F-457E-AFBD-D37B71FFA31D

Q26801593-602E49AC-4FCF-49C2-B49F-23FE67AB13F2

Q26801593-C6CE4EFC-470F-4284-8CAF-04FF6309D835

P932

Q26801593-32520435-64B8-4D7F-A88C-92B28CD7EE8D

P3181

P356

MOLCELLS.2015.0175

P1433

Molecules and Cells

P1476

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy

@en

P2093

Hyungjin Kim

http://www.w3.org/2001/XMLSchema#string

Ukhyun Jo

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of Rev1 by the Fanconi anemia core complex

A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway

A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability

MHF1-MHF2, a histone-fold-containing protein complex, participates in the Fanconi anemia pathway via FANCM

Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repair

Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair

DNA repair. Proteomics reveals dynamic assembly of repair complexes during bypass of DNA cross-links

A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair

Susceptibility pathways in Fanconi's anemia and breast cancer

Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy

P304

669-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4572201

http://www.w3.org/2001/XMLSchema#string

P356

10.14348/MOLCELLS.2015.0175

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280241506

http://www.w3.org/2001/XMLSchema#string

P698

26194820

http://www.w3.org/2001/XMLSchema#string

P921

P932

4546938

http://www.w3.org/2001/XMLSchema#string